Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2014

Open Access 01-12-2014 | Original investigation

Progressive decay of Ca2+ homeostasis in the development of diabetic cardiomyopathy

Authors: Shu-Mei Zhao, Yong-Liang Wang, Chun-Yan Guo, Jin-Ling Chen, Yong-Quan Wu

Published in: Cardiovascular Diabetology | Issue 1/2014

Login to get access

Abstract

Background

Cardiac dysfunction in diabetic cardiomyopathy may be associated with abnormal Ca2+ homeostasis. This study investigated the effects of alterations in Ca2+ homeostasis and sarcoplasmic reticulum Ca2+-associated proteins on cardiac function in the development of diabetic cardiomyopathy.

Methods

Sprague–Dawley rats were divided into 4 groups (n = 12, each): a control group, and streptozotocin-induced rat models of diabetes groups, examined after 4, 8, or 12 weeks. Evaluations on cardiac structure and function were performed by echocardiography and hemodynamic examinations, respectively. Cardiomyocytes were isolated and spontaneous Ca2+ spark images were formed by introducing fluorescent dye Fluo-4 and obtained with confocal scanning microscopy. Expressions of Ca2+-associated proteins were assessed by Western blotting.

Results

Echocardiography and hemodynamic measurements revealed that cardiac dysfunction is associated with the progression of diabetes, which also correlated with a gradual but significant decline in Ca2+ spark frequency (in the 4-, 8- and 12-week diabetic groups). However, Ca2+ spark decay time constants increased significantly, relative to the control group. Expressions of ryanodine receptor 2 (RyR2), sarcoplasmic reticulum Ca2+-2ATPase (SERCA) and Na+/Ca2+ exchanger (NCX1) were decreased, together with quantitative alterations in Ca2+regulatory proteins, FKBP12.6 and phospholamban progressively and respectively in the diabetic rats.

Conclusions

Ca2+ sparks exhibited a time-dependent decay with progression of diabetic cardiomyopathy, which may partly contribute to cardiac dysfunction. This abnormality may be attributable to alterations in the expressions of some Ca2+-associated proteins.
Appendix
Available only for authorised users
Literature
1.
go back to reference Fabiato A: Calcium-induced release of calcium from the cardiac sarcoplasmic reticulum. Am J Physiol. 1983, 245 (1): C1-C14.PubMed Fabiato A: Calcium-induced release of calcium from the cardiac sarcoplasmic reticulum. Am J Physiol. 1983, 245 (1): C1-C14.PubMed
2.
go back to reference Cheng H, Lederer WJ, Cannell MB: Calcium sparks: elementary events underlying excitation-contraction coupling in heart muscle. Science. 1993, 262 (5134): 740-744. 10.1126/science.8235594.CrossRefPubMed Cheng H, Lederer WJ, Cannell MB: Calcium sparks: elementary events underlying excitation-contraction coupling in heart muscle. Science. 1993, 262 (5134): 740-744. 10.1126/science.8235594.CrossRefPubMed
3.
go back to reference Hasenfuss G, Pieske B: Calcium cycling in congestive heart failure. J Mol Cell Cardiol. 2002, 34 (8): 951-969. 10.1006/jmcc.2002.2037.CrossRefPubMed Hasenfuss G, Pieske B: Calcium cycling in congestive heart failure. J Mol Cell Cardiol. 2002, 34 (8): 951-969. 10.1006/jmcc.2002.2037.CrossRefPubMed
4.
5.
go back to reference Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A: New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol. 1972, 30 (6): 595-602. 10.1016/0002-9149(72)90595-4.CrossRefPubMed Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A: New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol. 1972, 30 (6): 595-602. 10.1016/0002-9149(72)90595-4.CrossRefPubMed
6.
go back to reference Lacombe VA, Viatchenko-Karpinski S, Terentyev D, Sridhar A, Emani S, Bonagura JD, Feldman DS, Gyorke S, Carnes CA: Mechanisms of impaired calcium handling underlying subclinical diastolic dysfunction in diabetes. Am J Physiol Regul Integr Comp Physiol. 2007, 293 (5): R1787-R1797. 10.1152/ajpregu.00059.2007.PubMedCentralCrossRefPubMed Lacombe VA, Viatchenko-Karpinski S, Terentyev D, Sridhar A, Emani S, Bonagura JD, Feldman DS, Gyorke S, Carnes CA: Mechanisms of impaired calcium handling underlying subclinical diastolic dysfunction in diabetes. Am J Physiol Regul Integr Comp Physiol. 2007, 293 (5): R1787-R1797. 10.1152/ajpregu.00059.2007.PubMedCentralCrossRefPubMed
7.
go back to reference Choi KM, Zhong Y, Hoit BD, Grupp IL, Hahn H, Dilly KW, Guatimosim S, Lederer WJ, Matlib MA: Defective intracellular Ca(2+) signaling contributes to cardiomyopathy in type 1 diabetic rats. Am J Physiol Heart Circ Physiol. 2002, 283 (4): H1398-H1408.CrossRefPubMed Choi KM, Zhong Y, Hoit BD, Grupp IL, Hahn H, Dilly KW, Guatimosim S, Lederer WJ, Matlib MA: Defective intracellular Ca(2+) signaling contributes to cardiomyopathy in type 1 diabetic rats. Am J Physiol Heart Circ Physiol. 2002, 283 (4): H1398-H1408.CrossRefPubMed
8.
go back to reference Yaras N, Sariahmetoglu M, Bilginoglu A, Aydemir-Koksoy A, Onay-Besikci A, Turan B, Schulz R: Protective action of doxycycline against diabetic cardiomyopathy in rats. Br J Pharmacol. 2008, 155 (8): 1174-1184. 10.1038/bjp.2008.373.PubMedCentralCrossRefPubMed Yaras N, Sariahmetoglu M, Bilginoglu A, Aydemir-Koksoy A, Onay-Besikci A, Turan B, Schulz R: Protective action of doxycycline against diabetic cardiomyopathy in rats. Br J Pharmacol. 2008, 155 (8): 1174-1184. 10.1038/bjp.2008.373.PubMedCentralCrossRefPubMed
9.
go back to reference Bai SZ, Sun J, Wu H, Zhang N, Li HX, Li GW, Li HZ, He W, Zhang WH, Zhao YJ, Wang LN, Tian Y, Yang BF, Yang GD, Wu LY, Wang R, Xu CQ: Decrease in calcium-sensing receptor in the progress of diabetic cardiomyopathy. Diabetes Res Clin Pract. 2012, 95 (3): 378-385. 10.1016/j.diabres.2011.11.007.CrossRefPubMed Bai SZ, Sun J, Wu H, Zhang N, Li HX, Li GW, Li HZ, He W, Zhang WH, Zhao YJ, Wang LN, Tian Y, Yang BF, Yang GD, Wu LY, Wang R, Xu CQ: Decrease in calcium-sensing receptor in the progress of diabetic cardiomyopathy. Diabetes Res Clin Pract. 2012, 95 (3): 378-385. 10.1016/j.diabres.2011.11.007.CrossRefPubMed
10.
go back to reference Wen HL, Liang ZS, Zhang R, Yang K: Anti-inflammatory effects of triptolide improve left ventricular function in a rat model of diabetic cardiomyopathy. Cardiovasc Diabetol. 2013, 12: 50-10.1186/1475-2840-12-50.PubMedCentralCrossRefPubMed Wen HL, Liang ZS, Zhang R, Yang K: Anti-inflammatory effects of triptolide improve left ventricular function in a rat model of diabetic cardiomyopathy. Cardiovasc Diabetol. 2013, 12: 50-10.1186/1475-2840-12-50.PubMedCentralCrossRefPubMed
11.
go back to reference Wang GG, Li W, Lu XH, Zhao X, Xu L: Taurine attenuates oxidative stress and alleviates cardiac failure in type I diabetic rats. Croat Med J. 2013, 54 (2): 171-179. 10.3325/cmj.2013.54.171.PubMedCentralCrossRefPubMed Wang GG, Li W, Lu XH, Zhao X, Xu L: Taurine attenuates oxidative stress and alleviates cardiac failure in type I diabetic rats. Croat Med J. 2013, 54 (2): 171-179. 10.3325/cmj.2013.54.171.PubMedCentralCrossRefPubMed
12.
go back to reference Yaras N, Ugur M, Ozdemir S, Gurdal H, Purali N, Lacampagne A, Vassort G, Turan B: Effects of diabetes on ryanodine receptor Ca release channel (RyR2) and Ca2+ homeostasis in rat heart. Diabetes. 2005, 54 (11): 3082-3088. 10.2337/diabetes.54.11.3082.CrossRefPubMed Yaras N, Ugur M, Ozdemir S, Gurdal H, Purali N, Lacampagne A, Vassort G, Turan B: Effects of diabetes on ryanodine receptor Ca release channel (RyR2) and Ca2+ homeostasis in rat heart. Diabetes. 2005, 54 (11): 3082-3088. 10.2337/diabetes.54.11.3082.CrossRefPubMed
13.
go back to reference Picht E, Zima AV, Blatter LA, Bers DM: SparkMaster: automated calcium spark analysis with ImageJ. Am J Physiol Cell Physiol. 2007, 293 (3): C1073-C1081. 10.1152/ajpcell.00586.2006.CrossRefPubMed Picht E, Zima AV, Blatter LA, Bers DM: SparkMaster: automated calcium spark analysis with ImageJ. Am J Physiol Cell Physiol. 2007, 293 (3): C1073-C1081. 10.1152/ajpcell.00586.2006.CrossRefPubMed
14.
go back to reference Li J, Jia BH, Sun J, Lou XL, Hu SJ: Phospholamban antisense RNA improves SR Ca2 + −ATPase activity and left ventricular function in STZ-induced diabetic rats. Biomed Environ Sci. 2013, 26 (7): 577-583.PubMed Li J, Jia BH, Sun J, Lou XL, Hu SJ: Phospholamban antisense RNA improves SR Ca2 + −ATPase activity and left ventricular function in STZ-induced diabetic rats. Biomed Environ Sci. 2013, 26 (7): 577-583.PubMed
15.
go back to reference Piccini JP, Klein L, Gheorghiade M, Bonow RO: New insights into diastolic heart failure: role of diabetes mellitus. Am J Med. 2004, 116 (Suppl 5A): 64S-75S.CrossRefPubMed Piccini JP, Klein L, Gheorghiade M, Bonow RO: New insights into diastolic heart failure: role of diabetes mellitus. Am J Med. 2004, 116 (Suppl 5A): 64S-75S.CrossRefPubMed
16.
go back to reference Marks AR: Ryanodine receptors/calcium release channels in heart failure and sudden cardiac death. J Mol Cell Cardiol. 2001, 33 (4): 615-624. 10.1006/jmcc.2000.1343.CrossRefPubMed Marks AR: Ryanodine receptors/calcium release channels in heart failure and sudden cardiac death. J Mol Cell Cardiol. 2001, 33 (4): 615-624. 10.1006/jmcc.2000.1343.CrossRefPubMed
17.
go back to reference Bers DM: Cardiac excitation-contraction coupling. Nature. 2002, 415 (6868): 198-205. 10.1038/415198a.CrossRefPubMed Bers DM: Cardiac excitation-contraction coupling. Nature. 2002, 415 (6868): 198-205. 10.1038/415198a.CrossRefPubMed
18.
go back to reference MacLennan DH, Kranias EG: Phospholamban: a crucial regulator of cardiac contractility. Nat Rev Mol Cell Biol. 2003, 4 (7): 566-577. 10.1038/nrm1151.CrossRefPubMed MacLennan DH, Kranias EG: Phospholamban: a crucial regulator of cardiac contractility. Nat Rev Mol Cell Biol. 2003, 4 (7): 566-577. 10.1038/nrm1151.CrossRefPubMed
19.
go back to reference Mattiazzi A, Mundina-Weilenmann C, Guoxiang C, Vittone L, Kranias E: Role of phospholamban phosphorylation on Thr17 in cardiac physiologi-cal and pathological conditions. Cardiovasc Res. 2005, 68: 366-375. 10.1016/j.cardiores.2005.08.010.CrossRefPubMed Mattiazzi A, Mundina-Weilenmann C, Guoxiang C, Vittone L, Kranias E: Role of phospholamban phosphorylation on Thr17 in cardiac physiologi-cal and pathological conditions. Cardiovasc Res. 2005, 68: 366-375. 10.1016/j.cardiores.2005.08.010.CrossRefPubMed
20.
go back to reference Bhupathy P, Babu GJ, Periasamy M: Sarcolipin and phospholamban as regulators of cardiac sarcoplasmic reticulum Ca(2+) ATPase. J Mol Cell Cardiol. 2007, 42: 903-911. 10.1016/j.yjmcc.2007.03.738.PubMedCentralCrossRefPubMed Bhupathy P, Babu GJ, Periasamy M: Sarcolipin and phospholamban as regulators of cardiac sarcoplasmic reticulum Ca(2+) ATPase. J Mol Cell Cardiol. 2007, 42: 903-911. 10.1016/j.yjmcc.2007.03.738.PubMedCentralCrossRefPubMed
Metadata
Title
Progressive decay of Ca2+ homeostasis in the development of diabetic cardiomyopathy
Authors
Shu-Mei Zhao
Yong-Liang Wang
Chun-Yan Guo
Jin-Ling Chen
Yong-Quan Wu
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2014
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/1475-2840-13-75

Other articles of this Issue 1/2014

Cardiovascular Diabetology 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.